Evidence map›Paper›PMID 38790225›Full record

ArticleGenes2024

A Novel

Ludovico Graziani, Chiara Minotti, Miriam Lucia Carriero, Mario Bengala, Silvia Lai, Alessandra Terracciano, Antonio Novelli, Giuseppe Novelli

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ludovico GrazianiDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0002-7217-7388
Chiara MinottiDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0001-8616-5065
Miriam Lucia CarrieroDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0001-7339-6024
Mario BengalaMedical Genetics Unit, Tor Vergata University Hospital, 00133 Rome, Italy.
Silvia LaiDivision of Nephrology, Department of Translational and Precision Medicine, "Sapienza" University, 00133 Rome, Italy.ORCID 0000-0002-7199-2954
Alessandra TerraccianoTranslational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.
Antonio NovelliTranslational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.ORCID 0000-0002-9037-4297
Giuseppe NovelliDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0002-7781-602X

Funding

Ministero della Salute FSC 2014-2020, Project ID T3-AN-04 "GENERA"
6 · The paper itself

Abstract

Alport Syndrome (AS) is the most common genetic glomerular disease, and it is caused by

Indexed as

Collagen Type IVNephritis, HereditaryAdultFemaleFrameshift MutationHumansMalePedigreePhenotypePolycystic Kidney, Autosomal DominantPolycystic Kidney DiseasesCOL4A5 protein, humanCollagen Type IVAlport SyndromeCOL4A5phenotypic variabilitypolycystic kidney diseasesensorineural hearing loss

Identifiers

PMID38790225
PMCPMC11121527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.